BPC-157

Pentadecapeptide | Gastric Origin | Tissue Signalling Research

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids, originally derived from a protein sequence found in human gastric juice. It has been the subject of over 180 peer-reviewed studies indexed on PubMed as of 2025.

Research interest in BPC-157 centres on its interactions with several cellular signalling pathways, including vascular endothelial growth factor receptor 2 (VEGFR2), nitric oxide synthase (eNOS), and the early growth response gene (EGR-1). Animal models have examined its effects across gastrointestinal tissue, musculoskeletal structures, and the gut-brain axis.

BPC-157 is commonly used in preclinical studies investigating fibroblast proliferation, collagen synthesis, angiogenesis, and inflammatory marker modulation. It is supplied as a stable lyophilised powder suitable for controlled laboratory reconstitution and analysis.

Supplied as lyophilised powder. Purity ≥99% by HPLC. Third-party Certificate of Analysis available — tested by Janoshik Analytical (Prague) and issued in Longev Peptides' name.

For research use only. Not for human consumption.